We are finally getting a break in the move higher but it has been quiet impressive. There was less excitement in the move than I would have thought, which I.
The sector continues to rocket higher as clearly sentiment has reversed. This run likely has more legs than anyone thinks. The sector has been in a massive bear market and.
The sector seems to be breaking out of its range with another early show of strength. While it is still early and we have been here before, the background seems.
The market is certainly continuing its recent weakness (especially NASDAQ) but today biotech is down with it. Is this the start of another move to the lower end of its.
It is days like this that show why the sector cannot have nice things (as the saying goes). We seemed to be getting some traction and were approaching what has.
I want to end this week with an ASCO follow up and talking about something new. I must say that the sector is doing modestly better than I had feared.
I am back from ASCO with a lot to cover and I will focus on broader themes today and spend the rest of the week with more company specific commentary..
The sector sort of had some positive news yesterday with TSRO putting itself on the proverbial block. This obviously moved TSRO and sector as it reminded people that good things.
No news continues this week and now we are in a low volume bounce mode. It is unclear if it will hold but it might as it was not as.
There is no news to speak of so I want to end the week with some broader sector commentary. There are some broader undercurrents that seem to be continuing and.
The sector is having issues. If it is not in oversold conditions it certainly feels that way. Part of the issue is the traditional reasons to sell biotech but it.
I do not want to spend time on macro given the ASCO abstract dump. As I noted before there is usually not much that comes out of these abstracts as.
We have an interesting morning and likely next couple days of trading. The proximate cause of the selling is the continuing and escalating crisis with the Trump administration. While predicting.
While I do not want to say this with too high of a conviction but I am starting to believe sentiment has changed and is slowly improving. First, we are.
The sector seems to be doing OK. The market appears oddly bifurcated again with the large caps generally underperforming but there are some nice moves in the SMID. This is.
The news keeps coming in this week as the sector and market looks for a direction. I do not see anything happening that is fundamentally changing the story for the.
With the earning seasons continuing it is becoming clear that the sector is going to bifurcate. Growth is becoming increasingly difficult to find as the ability to grow through price.
I missed yesterday at home with a sick child. I need to catch up a little on what I missed but I wanted to follow up on the GILD quarter.